Skip to content

印孚瑟斯

US · INFY #508 按市值排名 上市于 1970
12.24 +0.11 +0.91%
实时 - 追踪5344个代码 - 心跳于73秒前 · 2026-10-16 20:02

✦ 量化股权信号 计算方式说明

增持
  • 最近一期（2026/Q3）披露持股的机构数量减少了9家。
  • 机构持股总比例上升了0.6个百分点。

机构持股

机构持股比例
68.45% +0.56pp
机构数量
712 -9
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund49.26%
Public Company13.32%
Individual/Insider2.56%
Hedge Fund1.32%
Government1.23%
Sovereign Wealth Fund1.11%
Private Company0.87%
Government Pension Fund0.81%
Corporate Pension Plan0.27%
Other29.24%

主要股东 截至 2026-05-20

Life Insurance Corporation of India 10.82% · 438.42M 股
BlackRock 4.97% · 201.19M 股
ICICI Prudential Asset Management Company Limited 4.39% · 177.65M 股
SBI Funds Management Limited 4.31% · 174.63M 股
Vanguard Capital Management, LLC 2.49% · 101.02M 股
Nandan Nilekani 2.48% · 100.47M 股
The Vanguard 2.44% · 98.91M 股
Nippon Life India Asset Management Limited 2.08% · 84.07M 股
HDFC Asset Management Company Limited 1.89% · 76.38M 股
UTI Asset Management Company Limited 1.64% · 66.44M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪33份申报 · 8次买入 · 12次卖出

姓名职务持股比例
Nandan Nilekani Chairperson 2.48%
Salil Parekh Chief Executive Officer 0.04%
Shaji Mathew Group Head of HR, Exec VP & Svc Offering Head of Fin Svcs, Healthcare, Ins and Life Sciences 0.01%
Inderpreet Sawhney Executive VP, Group General Counsel & Chief Compliance Officer 0.01%
Jayesh Sanghrajka Executive VP & Deputy CFO 0.00%
Bobby Parikh Independent Director 0.00%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-05-13 Jayesh Sanghrajka Executive VP & Deputy CFO Open Market Disposition -5,191 $11.41
2026-05-13 Inderpreet Sawhney Executive VP, Group General Counsel & Chief Compliance Officer Derivative Exercise and Sale -6,845 $0.00–0.12
2026-05-13 Shaji Mathew Group Head of HR, Exec VP & Svc Offering Head of Fin Svcs, Healthcare, Ins and Life Sciences Open Market Disposition -740 $11.41
2026-05-12 Inderpreet Sawhney Executive VP, Group General Counsel & Chief Compliance Officer Intent to Sell (Form 144) -6,845 $11.77
2026-05-07 Salil Parekh Chief Executive Officer Derivative Exercise and Sale -95,800 $0.05–12.47
2026-05-01 Salil Parekh Chief Executive Officer Other Derivative Acquisition +13,273 $5.00
2026-05-01 Salil Parekh Chief Executive Officer Other Derivative Acquisition +43,138 $5.00
2026-05-01 Salil Parekh Chief Executive Officer Other Derivative Acquisition +230,621 $5.00
2026-05-01 Salil Parekh Chief Executive Officer Derivative Exercise and Retained +148,094 $0.05
2026-03-30 Jayesh Sanghrajka Executive VP & Deputy CFO Other Derivative Acquisition +2,441 $0.05
2026-03-30 Inderpreet Sawhney Executive VP, Group General Counsel & Chief Compliance Officer Other Derivative Acquisition +4,880 $0.00
2026-03-30 Shaji Mathew Group Head of HR, Exec VP & Svc Offering Head of Fin Svcs, Healthcare, Ins and Life Sciences Other Derivative Acquisition +1,830 $0.05
2026-03-17 Nandan Nilekani Chairperson Initial Statement of Beneficial 0 --
2026-03-17 Bobby Parikh Independent Director Initial Statement of Beneficial 0 --
2026-03-17 Salil Parekh Chief Executive Officer Initial Statement of Beneficial 0 --
2026-03-17 Jayesh Sanghrajka Executive VP & Deputy CFO Initial Statement of Beneficial 0 --
2026-03-17 Inderpreet Sawhney Executive VP, Group General Counsel & Chief Compliance Officer Initial Statement of Beneficial 0 --
2026-03-17 Shaji Mathew Group Head of HR, Exec VP & Svc Offering Head of Fin Svcs, Healthcare, Ins and Life Sciences Initial Statement of Beneficial 0 --
2026-03-11 Inderpreet Sawhney Executive VP, Group General Counsel & Chief Compliance Officer Intent to Sell (Form 144) -6,550 $13.77
2026-02-14 Inderpreet Sawhney Executive VP, Group General Counsel & Chief Compliance Officer Derivative Exercise and Retained +4,745 $0.00

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:26 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

印孚瑟斯 讨论区 0 条评论

发表评论